Scholar Rock Financial Statements
NASDAQ: SRRKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
42.19-0.01 (-0.02%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Scholar Rock revenue and earnings
In fiscal 2025, Scholar Rock generated $0 in revenue. Scholar Rock reported a net loss of $377.9 million, compared with a loss of $246.3 million a year earlier. Diluted earnings per share came in at -$3.29.
Summary generated from market data by MetaCap's automated system. Methodology
Scholar Rock income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | — | — | 33.19M | 18.82M | 15.40M | 20.49M | 0 | — |
| Revenue growth (YoY) | — | — | — | +76.41% | +22.16% | -24.83% | — | — | — |
| Operating Expenses | 384.64M | 252.05M | 171.29M | 167.56M | 148.74M | 102.28M | 75.03M | 50.69M | 25.03M |
| Research & Development | 208.44M | 184.55M | 121.90M | 124.44M | 108.47M | 74.06M | 54.22M | 36.31M | 19.94M |
| Operating Income | -384.64M | -252.05M | -171.29M | -134.37M | -129.92M | -86.88M | -54.54M | -50.69M | -25.03M |
| Interest Expense | 6.89M | 6.84M | 6.50M | 4.70M | 2.10M | 400.00K | 27.00K | — | — |
| Other Income (Expense) | 6.71M | 5.76M | 5.51M | -132.00K | -1.88M | 395.00K | 3.54M | 1.37M | 34.00K |
| Pretax Income | -377.73M | -246.29M | — | — | — | — | — | — | — |
| Net Income | -377.94M | -246.29M | -165.79M | -134.50M | -131.80M | -86.48M | -51.00M | -49.33M | -25.00M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -3.29 | -2.47 | -1.99 | -2.26 | -3.59 | -2.81 | -1.85 | -3.15 | -15.30 |
| EPS (Diluted) | -3.29 | -2.47 | -1.99 | -2.26 | -3.59 | -2.81 | -1.85 | -3.15 | -15.30 |
| Shares Outstanding (Basic) | 114.70M | 99.84M | 83.35M | 59.61M | 36.71M | 30.73M | 27.54M | 15.66M | 1.63M |
| Shares Outstanding (Diluted) | 114.70M | 99.84M | 83.35M | 59.61M | 36.71M | 30.73M | 27.54M | 15.66M | 1.63M |
| EBITDA | -382.99M | -250.12M | -168.45M | -131.38M | -127.29M | -85.39M | -53.24M | -49.88M | -24.36M |
| Operating Margin | — | — | — | -404.81% | -690.48% | -564.03% | -266.16% | — | — |
| Net Margin | — | — | — | -405.21% | -700.46% | -561.47% | -248.88% | — | — |
This table shows 9 annual periods of Scholar Rock's income statement, from FY 2025 back to FY 2017, across 15 line items including revenue, operating expenses, research & development. Values in USD; B = billions, M = millions. Fiscal periods follow SRRK's reporting calendar. What is a income statement?